IDDI is an Expert Biostatistical Services Provider
IDDI is recognized as leader in the field of protocol design, biostatistical analyses, biomarker qualification, meta-analyses, IDMC reports and clinical study reports.
> Since 1991, the company has maintained the same focus and honed its biostatistics skills.
Almost a third of the staff is made up of qualified biostatisticians.
> The quality of the analyses depends on the quality of the data collected.
IDDI has a strong data management team who ensures database setup, data collection and data management according to the highest quality standards.
> IDDI's expertise is entirely focused on bringing scientific depth to deliver clinical trial results that are scientifically accurate, validated and reproducible.
This requires excellence in people and competence, clinical trial data expertise thanks to advanced methodology and innovative web systems as well as a thorough knowledge of the diseases for which clinical trials are conducted.
> The company's core area of expertise is oncology with substantial experience in ophthalmology and cardiovascular diseases.
> IDDI has contributed to securing numerous regulatory approvals for its clients.
> IDDI's broad range of expertise is reflected in its publications (350+) in medical and statistical journals and its presence at major meetings and conferences.
> IDDI's main clients are pharmaceutical and biotechnology companies in Europe and the United States.
Over the last 5 years:
-
300+ phase I to IV clinical trials
-
70+ IDMCs
Since 2000:
-
IDDI has helped bring 14 compounds to market.
The following charts show the breakdown of IDDI projects over the last 5 years by:
-
Geographical review - click here for details
-
Research phases (I through IV) - click here for details
-
Therapeutic areas - click here for details
-
Tumor types (for oncology projects) - click here for details
